Literature DB >> 1160196

Toxicities of influenza vaccine: peripheral leukocytic response to live and inactivated influenza viruses in mice.

M Kurokawa, S Ishida, S Asakawa, S Iwasa, N Goto.   

Abstract

Intraperitoneal or intravenous inoculation of live or inactivated influenza virus induced two characteristic responses of the peripheral leukocytes in mice, an early appearing leukopenic response and late appearing lymphopenia. The former response usually developed and subsided within several hours, though the change in leukocyte population was fairly complicated depending upon the activity of the inoculated material, while the latter began several hours after inoculation and reached its minimum level in 10 to 20 hr. The agent responsible for the former may be virus pyrogen, while the latter seems to be caused by some substance(s) other than that. The early appearing leukopenic response was similar to that due to bacterial endotoxin in respect to the characteristic pattern of the change in peripheral leukocyte population, though it was relatively easy to distinguish one from the other by the length of the latent period and by the heat stability of the causative agent. Live or inactivated influenza virus causing the early appearing leukopenic response was found also to have the mouse body weight-decreasing toxicity. The significance of these findings in the laboratory control test of influenza vaccine for untoward reactions often observed in human inoculated with some inactivated influenza vaccines was discussed. The possible roles of the two agents, virus pyrogen and endotoxin, in the febrile response were mentioned.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1160196     DOI: 10.7883/yoken1952.28.37

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN: 0021-5112


  5 in total

1.  A reduction in the number of peripheral CD28+CD8+T cells in the acute phase of influenza.

Authors:  S Nabeshima; M Murata; K Kikuchi; H Ikematsu; S Kashiwagi; J Hayashi
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 2.  A new method for the evaluation of vaccine safety based on comprehensive gene expression analysis.

Authors:  Haruka Momose; Takuo Mizukami; Masaki Ochiai; Isao Hamaguchi; Kazunari Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-13

3.  Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Keiko Furuhata; Mamiko Takai; Hideki Asanuma; Ken J Ishii; Takuo Mizukami; Isao Hamaguchi
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

4.  Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice.

Authors:  Eita Sasaki; Hideki Kusunoki; Haruka Momose; Keiko Furuhata; Kazuo Hosoda; Kaori Wakamatsu; Takuo Mizukami; Isao Hamaguchi
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

5.  Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine.

Authors:  Eita Sasaki; Haruka Momose; Yuki Hiradate; Keiko Furuhata; Takuo Mizukami; Isao Hamaguchi
Journal:  Oncotarget       Date:  2018-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.